The Vanguard Group Discloses Position in Spire Healthcare

The Vanguard Group, Inc. has filed a Form 8.3 regarding its interest in Spire Healthcare Group plc. As of July 24, 2026, Vanguard holds 3.54% interest in Spire through 14,274,732 relevant securities. This disclosure follows Rule 8.3 of the UK Takeover Code, which mandates public opening position disclosures by entities with interests exceeding 1% in relevant securities.

Vanguard reported selling 1,323 ordinary shares at a price of 2.24 GBP each. No derivative positions or new subscription rights were disclosed, and no informal or formal agreements were reported relating to options or derivatives. The disclosure emphasizes compliance with regulatory standards as required by the Code.